- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens introduces high-end ultrasound class
The S-2000 ultrasound scanner, takes shape this week as a new commercial product at the high end of the Siemens Medical Systems’ ultrasound portfolio. The S-2000, cleared by the FDA in mid-October, does not replace the Sequoia, Siemens’ flagship since it acquired ultrasound pioneer Acuson six years ago. Instead, it complements the system, according to Siemens executives, by combining best-of-breed technologies from Sequoia with Siemens’ ultrasound platforms developed prior to the Acuson acquisition.
The S-2000 ultrasound scanner, takes shape this week as a new commercial product at the high end of the Siemens Medical Systems' ultrasound portfolio. The S-2000, cleared by the FDA in mid-October, does not replace the Sequoia, Siemens' flagship since it acquired ultrasound pioneer Acuson six years ago. Instead, it complements the system, according to Siemens executives, by combining best-of-breed technologies from Sequoia with Siemens' ultrasound platforms developed prior to the Acuson acquisition.
The new scanner is the first in the new S-Class of ultrasound systems, which Siemens will position at the top of its ultrasound portfolio. The S-2000 includes an elastographic capability, called Acoustic Radiation Forced Impulse, which the company is framing as the biggest change in the industry since Doppler imaging. This capability, yet to be cleared by the FDA, uses varying acoustic energies to assess tissue stiffness. This may help evaluate abnormalities such as liver tumors or fibrosis. The architecture of the S-2000 system is designed to accommodate a transducer technology in development, Silicon Ultrasound, which promises to enable isotropic 3D imaging over a wide range of applications. The S-2000 will also be able to handle Siemens' pending Automated Breast Scanning, a technique that provides automated, reproducible 3D ultrasound of the breast.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
FDA Clears AI-Powered Cardiovascular Ultrasound System from Siemens Healthineers
August 13th 2024Offering a variety of AI features for streamlined workflow and enhanced visualization, the Acuson Origin ultrasound system also features the newly FDA-cleared AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.
